Literature DB >> 14666193

Spectrum of mutations in BRCA1 gene in hereditary forms of breast and ovarian cancer in Russian families.

A N Loginova1, N I Pospekhova, L N Lyubchenko, A V Budilov, V M Zakhar'ev, R F Gar'kavtseva, E K Ginter, A V Karpukhin.   

Abstract

The 5382insC mutation predominated (94%) in the spectrum of detected mutations of BRCA1 gene. High incidence of this mutation in familial breast cancer detected for the first time attested to origination of 5382insC mutation from the European part of Russia. The percentage of families with mutations in BRCA1 gene and familial predisposition to ovarian cancer was significantly higher than in hereditary predisposition to breast cancer (p<0.007). These data suggest that clinical manifestation of the mutation depends on genotypical factors other than the position of this mutation in BRCA1 gene. The results prompt screening for hereditary predisposition to these diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14666193     DOI: 10.1023/b:bebm.0000008982.21806.9b

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  9 in total

1.  High prevalence of two BRCA1 mutations, 4154delA and 5382insC, in Latvia.

Authors:  Laima Tikhomirova; Olga Sinicka; Dagnija Smite; Janis Eglitis; Shirley V Hodgson; Aivars Stengrevics
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

2.  Complete BRCA mutation screening in breast and ovarian cancer predisposition families from a North-Eastern Romanian population.

Authors:  Lucian Negura; Nancy Uhrhammer; Anca Negura; Vlad Artenie; Eugen Carasevici; Yves-Jean Bignon
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

3.  Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976-1999.

Authors:  Gabriel Chodick; Jeffery P Struewing; Elaine Ron; Joni L Rutter; Jose Iscovich
Journal:  Eur J Med Genet       Date:  2007-11-22       Impact factor: 2.708

4.  BRCA1 mutations in women with familial or early-onset breast cancer and BRCA2 mutations in familial cancer in Estonia.

Authors:  Kristiina Tamboom; Krista Kaasik; Jelena Aršavskaja; Mare Tekkel; Aili Lilleorg; Peeter Padrik; Andres Metspalu; Toomas Veidebaum
Journal:  Hered Cancer Clin Pract       Date:  2010-04-09       Impact factor: 2.857

5.  Contribution of the Defective BRCA1, BRCA2 and CHEK2 Genes to the Familial Aggregation of Breast Cancer: a Simulation Study Based on the Swedish Family-Cancer Database.

Authors:  Justo Lorenzo Bermejo; Alfonso García Pérez; Kari Hemminki
Journal:  Hered Cancer Clin Pract       Date:  2004-11-15       Impact factor: 2.857

6.  New germline BRCA2 gene variant in the Tuvinian Mongol breast cancer patients.

Authors:  Polina Gervas; Boris Klyuch; Evgeny Denisov; Artem Kiselev; Alexey Molokov; Lubov Pisareva; Elena Malinovskaya; Evgeny Choynzonov; Nadezda Cherdyntseva
Journal:  Mol Biol Rep       Date:  2019-07-04       Impact factor: 2.316

7.  Prevalence of the most frequent BRCA1 mutations in Polish population.

Authors:  Izabela Brozek; Celina Cybulska; Magdalena Ratajska; Magdalena Piatkowska; Anna Kluska; Aneta Balabas; Michalina Dabrowska; Dorota Nowakowska; Anna Niwinska; Jolanta Pamula-Pilat; Karolina Tecza; Wioletta Pekala; Jolanta Rembowska; Karina Nowicka; Maria Mosor; Danuta Januszkiewicz-Lewandowska; Jadwiga Rachtan; Ewa Grzybowska; Jerzy Nowak; Jan Steffen; Janusz Limon
Journal:  J Appl Genet       Date:  2011-04-19       Impact factor: 3.240

8.  Hereditary breast-ovarian cancer syndrome in Russia.

Authors:  A P Sokolenko; A G Iyevleva; N V Mitiushkina; E N Suspitsin; E V Preobrazhenskaya; E Sh Kuligina; D A Voskresenskiy; O S Lobeiko; N Yu Krylova; T V Gorodnova; K G Buslov; E M Bit-Sava; G D Dolmatov; N V Porhanova; I S Polyakov; S N Abysheva; A S Katanugina; D V Baholdin; G A Yanus; A V Togo; V M Moiseyenko; S Ya Maximov; V F Semiglazov; E N Imyanitov
Journal:  Acta Naturae       Date:  2010-10       Impact factor: 1.845

9.  Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.

Authors:  Ramūnas Janavičius
Journal:  EPMA J       Date:  2010-06-27       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.